These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9884373)

  • 1. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity.
    Genth-Zotz S; Zotz R; Geil S; Voigtländer T; Meyer J; Darius H
    Circulation; 1999 Jan 5-12; 99(1):18-21. PubMed ID: 9884373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.
    Fazio S; Sabatini D; Capaldo B; Vigorito C; Giordano A; Guida R; Pardo F; Biondi B; Saccà L
    N Engl J Med; 1996 Mar; 334(13):809-14. PubMed ID: 8596546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status.
    Acevedo M; Corbalán R; Chamorro G; Jalil J; Nazzal C; Campusano C; Castro P
    Int J Cardiol; 2003 Feb; 87(2-3):185-91. PubMed ID: 12559539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function.
    Osterziel KJ; Ranke MB; Strohm O; Dietz R
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):61-8. PubMed ID: 10931081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis.
    Tritos NA; Danias PG
    Endocr Pract; 2008; 14(1):40-9. PubMed ID: 18238740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.
    van Thiel SW; Smit JW; de Roos A; Bax JJ; van der Wall EE; Biermasz NR; Viergever E; Vliegen HW; Romijn JA; Roelfsema F; Lamb HJ
    Int J Cardiovasc Imaging; 2004 Feb; 20(1):53-60. PubMed ID: 15055821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement in cardiac morphology and function in young rats with dilated cardiomyopathy by recombinant human growth hormone].
    Cheng SQ; Qiang H; Fu R; Pan KL
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 May; 17(5):508-14. PubMed ID: 26014705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
    Klecha A; Kawecka-Jaszcz K; Bacior B; Kubinyi A; Pasowicz M; Klimeczek P; Banyś R
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):85-91. PubMed ID: 17301632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics.
    Lele SS; Thomson HL; Seo H; Belenkie I; McKenna WJ; Frenneaux MP
    Circulation; 1995 Nov; 92(10):2886-94. PubMed ID: 7586256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
    Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
    Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.
    Smit JW; Janssen YJ; Lamb HJ; van der Wall EE; Stokkel MP; Viergever E; Biermasz NR; Bax JJ; Vliegen HW; de Roos A; Romijn JA; Roelfsema F
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4638-43. PubMed ID: 11600518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced left ventricular performance in endurance trained older men.
    Seals DR; Hagberg JM; Spina RJ; Rogers MA; Schechtman KB; Ehsani AA
    Circulation; 1994 Jan; 89(1):198-205. PubMed ID: 8281647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between exercise capacity and left ventricular function at rest in patients with heart insufficiency: radionuclide continuous monitoring of left ventricular function].
    Pace L; Nappi A; Imbriaco M; Cuocolo A; Varrone A; Romano M; Trimarco B; Salvatore M
    Radiol Med; 2000 Sep; 100(3):120-5. PubMed ID: 11148876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
    Borlaug BA; Koepp KE; Melenovsky V
    J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy.
    Lapu-Bula R; Robert A; De Kock M; D'Hondt AM; Detry JM; Melin JA; Vanoverschelde JL
    Am J Cardiol; 1999 Mar; 83(5):728-34. PubMed ID: 10080427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of terminal dilated cardiomyopathy with growth hormone].
    Dreifuss P
    Z Kardiol; 1998 Jun; 87(6):425-35. PubMed ID: 9691412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.